NCT01322282View on ClinicalTrials.gov

To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Allergy
Interventions
DRUG

Cetirizine

A single 10 mg dose of an experimental Cetirizine Orodispersible Tablet (ODT), with a 7-day washout period between visits

DRUG

Cetirizine

A single 10 mg dose of a marketed Cetirizine Film-Coated Tablet (FCT), with a 7-day washout period between visits

Trial Locations (1)

H3P 3P1

Algorithme Pharma Inc., Mount Royal

Sponsors

Lead Sponsor

McNeil AB
All Listed Sponsors
lead

McNeil AB

INDUSTRY